Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales (2020 - 2025)

Historic Return on Sales for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 0.13%.

  • Journey Medical's Return on Sales rose 300.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.26% for FY2024, which is 2100.0% down from last year.
  • Per Journey Medical's latest filing, its Return on Sales stood at 0.13% for Q3 2025, which was up 300.0% from 0.25% recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Return on Sales ranged from a high of 0.49% in Q3 2023 and a low of 1.24% during Q4 2021
  • Its 5-year average for Return on Sales is 0.37%, with a median of 0.31% in 2025.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -14000bps in 2021, then surged by 11100bps in 2023.
  • Quarter analysis of 5 years shows Journey Medical's Return on Sales stood at 1.24% in 2021, then surged by 46bps to 0.67% in 2022, then soared by 79bps to 0.14% in 2023, then soared by 183bps to 0.12% in 2024, then crashed by -213bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q3 2025, compared to 0.25% in Q2 2025 and 0.31% in Q1 2025.